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Summary
Background: Vasospastic angina (VSA) is closely related to endothelial dysfunction caused by
oxidative damage. Manganese superoxide dismutase (MnSOD) is an antioxidant enzyme that
functions in mitochondria. There are two genetic variants of MnSOD arising from a substitution
of an alanine for a valine in the signal peptide. We previously reported that the valine allele
of MnSOD decreases the mitochondrial MnSOD (mtMnSOD) activity. Here, we investigated the
association of the MnSOD polymorphism (Ala16Val) with VSA.
Methods and results: Blood samples were collected from 618 healthy subjects who did not have
any symptoms or other evidence suggesting angina pectoris, and 228 patients who underwent
coronary angiography on suspicion of angina, and were diagnosed to have VSA by acetylcholine
test. MnSOD genotype of each subject was determined by real-time polymerase chain reaction.
The valine allele frequency was higher in the VSA patients (0.890) than in the healthy subjects
(0.839) [odds ratio (OR) = 1.55, p = 0.0085]. In healthy subjects the MnSOD genotype distribution
was as follows: alanine/alanine 1.9%, alanine/valine 28.3%, and valine/valine 69.8%, and in VSA
patients the prevalence was: alanine/alanine 1.3%, alanine/valine 19.3%, and valine/valine
79.4%. Thus, the valine allele was closely associated with VSA (p = 0.019). Multivariate logistic
regression analysis showed valine/valine homozygosity to be an independent risk factor for VSA
(OR = 2.02, 95% CI 1.43, 2.85; p = 0.0012).
Conclusion: The valine variant o
© 2009 Japanese College of Car
∗ Corresponding author. Tel.: +81 3 3588 1111;
fax: +81 3 3582 7068.
E-mail address: hafujimoto-circ@umin.ac.jp (H. Fujimoto).
I
V
p
l
0914-5087/$ — see front matter © 2009 Japanese College of Cardiology.
doi:10.1016/j.jjcc.2009.10.011f MnSOD signal peptide increases the risk of VSA.
diology. Published by Elsevier Ireland Ltd. All rights reserved.ntroduction
asospastic angina (VSA) plays an important role in the
athogenesis of ischemic heart disease, and sometimes
eads to dire consequences such as acute coronary syndrome
Published by Elsevier Ireland Ltd. All rights reserved.
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r arrhythmic cardiac arrest [1—4]. VSA is a common disease
ll over the world, but it is more prevalent in the Japanese
nd Korean populations than in Caucasians [5,6].
VSA is closely related to the endothelial dysfunction
aused by oxidative damage [7—9]. Manganese superoxide
ismutase (MnSOD) is an antioxidant enzyme that functions
n mitochondria [10,11]. A number of reports have sug-
ested that MnSOD protects endothelial function [12,13],
nd reduces the damage inﬂicted on vascular wall cells by
xidized low-density lipoprotein (oxLDL) [14,15]. There are
wo genetic variants of MnSOD arising from a substitution
f an alanine for a valine in the signal peptide. We pre-
iously reported that the valine allele of MnSOD decreases
he mitochondrial MnSOD (mtMnSOD) activity, and the toler-
nce of the cells against oxLDL, thereby increasing the risk
f coronary artery disease [16]. It is known that the distribu-
ion of MnSOD genotype is associated with ethnicity, and the
revalence of the valine/valine genotype of MnSOD is higher
n the Japanese population than in Westerners [11,17,18].
ased on these ﬁndings, we hypothesized that the MnSOD
enetic polymorphism may be related to the prevalence of
SA.
In this study, we investigated the association of MnSOD
ene polymorphism with VSA.
aterials and methods
ubjects
his study complied with the principles of the Declaration
f Helsinki concerning the participation of human subjects
n clinical studies. The study protocol was approved by
he Ethics Committee of each hospital participating in the
tudy. The study was explained to every subject and written
nformed consent was obtained.
To investigate the association between the MnSOD poly-
orphism and VSA, a total of 846 Japanese subjects were
nrolled consisting of 618 healthy subjects, 38—76 years old,
nd 228 VSA patients, 31—83 years old. The 618 healthy
ubjects were recruited at their annual health examina-
ion at Mitsui Memorial Hospital, Tokyo, Japan, between May
nd November 2000, and did not have any chest symptoms
r electrocardiogram (ECG) abnormalities suggesting CAD,
r a medical history of CAD. The 228 VSA patients were
ecruited at the Cardiovascular Institute Hospital, Tokyo,
apan, and were enrolled by the examination of 828 sub-
ects who underwent coronary angiography (CAG) between
ovember 1999 and July 2000 for the ﬁrst time in their
ives on suspicion of coronary artery disease because of
hest symptoms or ECG abnormalities. Acetylcholine test
as performed for the 353 patients who had no lesions
ith a percent diametric stenosis of 50% or more in their
oronary arteries. Acetylcholine chloride dissolved in 5ml
f 0.9% saline was injected in incremental doses of 25, 50,
nd 100g into the left coronary artery and then 25 and
0g into the right coronary artery. VSA was diagnosed when
otal or sub-total occlusion of coronary artery accompany-
ng the symptoms of myocardial ischemia was induced by
ntra-coronary injection of the drug. Acetylcholine test was
ositive in 228 of the 353 patients. Therefore, we enrolled
he 228 patients in the study.
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nSOD genotyping
nSOD genotypes were analyzed as previously described
16]. In brief, a 5ml blood specimen was collected
nto a tube containing ethylenediaminetetraacetic acid
EDTA; ﬁnal concentration 5mM), from every subject.
he genomic DNA was extracted from leukocytes using
IAamp blood kit (Qiagen, Tokyo, Japan). The genotype
as determined by a ﬂuorescence-based allele-speciﬁc
olymerase chain reaction and melting curve analy-
is using a Light CyclerTM System (Roche Diagnostics,
annheim, Germany). The polymerase chain reaction
as performed using two ampliﬁcation primers (forward
rimer: 5′-AGCCCAGCCGTGCGTAGA-3′, and reverse primer:
′-GCGTGGTGCTTGCTGTGG-3′). An initial denaturation of
NA was accomplished at 95 ◦C for 1min, followed by 40
ycles of denaturation at 95 ◦C for 10 s, annealing at 63 ◦C for
0 s, and elongation at 72 ◦C for 8 s. Melting curve analysis
as performed using an upstream ﬂuorescent probe (5′-
CAGGTCGGGGAGGCTGTGCTTCTGCCTGGAGCCCA-3′-Fluo-
escein) and a downstream probe (LightCyclerRed640-5′-
TACCCCAAAACCGGAG-3′-phosphate). The DNA samples
ere selected randomly and assessed in the same batch by
laboratory technician blinded to the patient origin of the
amples.
tatistical analysis
uantitative data are presented as mean± standard devia-
ion, and the categorical data as frequencies (percentage).
ontinuous variables were compared using the unpaired t-
est. Binary variables were compared by means of the Fisher
xact test, and the variables comprising more than two cat-
gorical factors were compared by means of the chi-square
est. To identify the risk factors of VSA, univariate logistic
egression analysis was performed using the valine/valine
enotype and conventional coronary risk factors of VSA such
s gender, age, hypertension, hyperlipidemia, diabetes, and
moking, as independent variables. Then, a multivariate
ogistic regression model was used to test the signiﬁcance of
he genotype after controlling for the other variables listed
bove. Odds ratios (ORs) were calculated as an estimate of
elative risk of VSA associated with the valine/valine geno-
ype. A p-value of less than 0.05 was considered statistically
igniﬁcant. All statistical analyses were performed using JMP
software (SAS Institute, Cary, NC, USA).
esults
ssay of genetic polymorphisms
he dF/dT (F: ﬂuorescence signal, T: temperature, dF/dT:
he rate of change of the ﬂuorescent signal with temper-
ture) versus temperature curve of DNA corresponding to
ach MnSOD genotype is shown in Fig. 1. The alanine/alanine
enotype had one peak centered at about 49.5 ◦C; the
aline/valine genotype had one peak centered at about
9.5 ◦C, and the alanine/valine genotype had two peaks cen-
ered at about 49.5 ◦C and 59.5 ◦C. Among all subjects, we
ould not identify the genotypes of two samples from the
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Figure 1 A plot of temperature versus −dF/dT for the detec-
tion of manganese superoxide dismutase genotype by Light
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rycler analysis. F, intensity of ﬂuorescent signal from LCRed;
, temperature; dF/dT, the rate of change of the ﬂuorescent
ignal with temperature.
ealthy subjects because we could not ﬁnd a peak at either
9.5 ◦C or 59.5 ◦C. The genotyping error rate was 0.24%.
n total, 616 healthy subjects and 228 VSA patients were
ncluded in the analysis.
haracteristics of the enrolled subjects
he characteristics of the subjects enrolled in the study are
hown in Table 1. The prevalence of hypertension, diabetes
ellitus, hypercholesterolemia, and smoking was higher in
he VSA patients than in the healthy subjects. No signiﬁcant
ifference could be found in the distribution of risk factors
etween the three genotypes both in healthy subjects and
SA patients.
istribution of MnSOD genotypes in healthy
ubjects and in VSA patients
he MnSOD genotype distribution among the 616 healthy
ubjects was as follows: alanine/alanine 12 subjects (1.9%),
lanine/valine 174 subjects (28.3%), and valine/valine 430
ubjects (69.8%), and was compatible with Hardy—Weinberg
quilibrium. This distribution was similar to that previously
eported [11,18].
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Table 2 Logistic regression analysis for risk factors and for the valine/valine genotype in relation to VSA.
OR (95% CI) P
A. Univariate logistic regression analysis
Male 1.28 (0.90, 1.81) 0.167
Age (per year) 1.03 (1.02, 1.05) <0.0001
Hypertension 1.46 (1.03, 2.07) 0.033
Hyperlipidemia 2.66 (1.94, 3.64) <0.0001
Diabetes mellitus 2.43 (1.41, 4.19) 0.0014
Smoking 2.48 (1.79, 3.43) <0.0001
Valine/valine 1.67 (1.16, 2.40) 0.0060
OR (95% CI) P
B. Multivariate logistic regression analysis
Male 1.00 (0.68, 1.46) 0.99
Age (per year) 1.03 (1.01, 1.05) 0.0007
Hypertension 1.49 (0.94, 2.38) 0.092
Hyperlipidemia 2.71 (1.85, 3.95) <0.0001
Diabetes mellitus 1.80 (0.94, 3.48) 0.079
0.0005
0.0012
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(30.4%), and valine/valine 84 patients (67.2%). The distri-
bution of MnSOD genotype was closely associated with VSA
(p = 0.040 by chi-square analysis), that is, the valine allele
was related to the presence of VSA (Table 3). The valine
allele frequency in the 125 non-VSA patients was 0.824, and
signiﬁcantly lower than that in the 228 VSA patients (OR
1.73, p = 0.013, by chi-square analysis; Table 3).
Discussion
The major ﬁnding of our study is the signiﬁcant associa-
tion of the MnSOD polymorphism with VSA. The valine allele
was closely related to VSA, and the valine/valine genotype
was found to be an independent genetic risk factor of VSA.
Although the prevalence of VSA in the world has not been
precisely investigated, it is well known that the distribu-
tion of VSA has a signiﬁcant association with ethnicity. That
is, VSA is more common in the Japanese and Korean pop-
ulations than in Caucasians [5,6]. Thus far, several genetic
Table 3 Distribution of manganese superoxide dismutase
genotypes in the patients diagnosed not to have vasospastic
angina (VSA) by coronary angiography (CAG).
Genotype Non-VSA
patientsa
(n = 125)
VSA patient
(n = 228)
Alanine/alanine (%) (n) 2.4 (3) 1.3 (3)†
Alanine/valine (%) (n) 30.2 (38) 19.3 (44)†
Valine/valine (%) (n) 67.2 (84) 79.4 (181)†
Allele frequency 0.176/0.824 0.110/0.890‡Smoking 2.10 (1.39, 3.17)
Valine/valine 2.02 (1.43, 2.85)
By contrast, the MnSOD genotype distribution in the
28 VSA patients was: alanine/alanine 3 patients (1.3%),
lanine/valine 44 patients (19.3%), and valine/valine 181
atients (79.4%). The distribution of MnSOD genotype was
losely associated with VSA (p = 0.019 by chi-square analy-
is), that is, the valine allele was related to the presence of
SA.
The valine allele frequency was higher in the VSA patients
0.890) than in the healthy subjects (0.839) (OR = 1.55,
= 0.0085 by chi-square analysis).
ogistic regression analysis
ext, we performed logistic regression analysis to investi-
ate the role of the valine/valine genotype as a risk factor of
SA. According to the univariate logistic regression analysis,
he valine/valine genotype was associated with VSA with an
R of 1.67 (95% CI 1.16, 2.40; p = 0.0060, Table 2A). Further-
ore, a multivariate logistic regression analysis revealed
hat the valine/valine genotype as well as age, smoking,
nd hypercholesterolemia, were independent risk factors
or VSA (OR = 2.02, 95% CI 1.43, 2.85; p < 0.0012, Table 2B).
istribution of MnSOD genotypes in the patients
ho underwent CAG and were diagnosed not to
ave VSA
o exclude the selection bias, we analyzed the distribution
f the MnSOD genotypes in the 125 patients who underwent
AG, and were diagnosed to have neither atherosclerotic
oronary artery disease nor VSA by CAG. These 125 patients
ad no stenotic lesions with percent diametric stenosis of
0% or more. All of them underwent acetylcholine test
r ergonovine test, and the results were negative. The
nSOD genotype distribution in these 125 patients was: ala-
ine/alanine 3 patients (2.4%), alanine/valine 38 patients
(alanine/valine)
a Those who underwent CAG, but were diagnosed to have nei-
ther severe stenotic lesions nor vasospasm.
† P = 0.040 by chi-square analysis.
‡ Odds ratio 1.73, P = 0.013 by chi-square analysis.
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[Association of the manganese superoxide dismutase polymo
polymorphisms have been reported to have an association
with VSA [19—23]. But many of these polymorphisms could
not explain the distribution of VSA with respect to ethnic
origin. MnSOD genotype distribution is also associated with
ethnicity, and the valine allele frequency is higher in the
Japanese than in Caucasians [11,17,18]. Thus, our data will
provide an important clue to clarify the ethnicity association
of VSA.
In this study, univariate and multivariable logistic regres-
sion analysis showed that hyperlipidemia, smoking, and
aging to be the most meaningful risk factor for VSA as
previously reported [24,25]. Our data revealed that the
valine/valine genotype of MnSOD as well as hyperlipidemia,
smoking, and aging are independent risk factors of VSA.
Despite the ﬁnding that the odds ratio of the valine/valine
genotype for VSA is lower than the other conventional risk
factors, our data provide evidence that oxidative damage
plays an important role in the pathogenesis of VSA.
There are many basic and clinical data that suggest that
endothelial dysfunction plays a key role in the pathogene-
sis of vasospasm [7—9,26,27]. There are also several reports
that superoxide radicals damage endothelial function, and
superoxide dismutase acts protectively for the endothelial
cells [28—30]. OxLDL enhances coronary vasoconstriction
by increasing the activity of speciﬁc protein kinase C iso-
forms in coronary smooth muscle [31]. From these data,
it may be suggested that oxidative damage in endothelial
cells and smooth muscle cells is closely associated with vaso-
constriction. Hypercontraction of smooth muscle cells also
plays an important role in vasospasm [32]. It is reported
that smooth muscle cell hypercontraction is mediated by
oxidative stress-related effectors such as Rho-kinase [33].
Therefore, there is a possibility that the reduction in the tol-
erance against oxidative stress by the valine allele of MnSOD
may be related to the hypercontraction of smooth mus-
cle cells, thereby increasing the risk of VSA. We previously
reported that the valine allele of MnSOD is associated with
reduction of the mitochondrial MnSOD activity and the tol-
erance of macrophages against apoptosis induced by oxLDL
[16]. We did not investigate the differences in the function
of endothelial cells and smooth muscle cells for each geno-
type group because of the difﬁculty in sampling these cells.
But since the intracellular signaling pathway appears to be
similar for various types of vascular wall cells, the MnSOD
polymorphism may also be associated with the tolerance of
both endothelial cells and smooth muscle cells against oxida-
tive damage, thereby modifying the risk of atherosclerosis
and vasospasm.
Study limitation
We enrolled 618 healthy subjects with no signs of angina
pectoris. But we did not demonstrate that they did not have
atherosclerotic coronary artery disease or VSA by examina-
tions such as exercise test or CAG. Thus, there is a possibility
that unsymptomatic VSA patients are included in the 618
healthy subjects. Despite this, we conﬁrmed the associa-
tion of MnSOD polymorphism with VSA by another analysis
enrolling 228 VSA patients and 125 subjects demonstrated
not to have VSA by acetylcholine test. A study with a larger
population comparing the VSA patients and control subjectsm with vasospastic angina pectoris 209
igorously diagnosed not to have VSA is necessary to obtain
ore convincing evidence.
onclusions
ur data indicate that the valine variant of MnSOD signal
eptide increases the risk of VSA, and the valine/valine
enotype is an independent genetic risk factor of VSA. Our
esults provide an important clue to clarify the role of oxida-
ive stress in VSA and the distribution of VSA with respect to
thnic origin.
eferences
[1] Yasue H, Omote S, Takizawa A, Nagao M. Coronary arterial
spasm in ischemic heart disease and its pathogenesis: a review.
Circ Res 1983;52:I-147—52.
[2] Nakamura M, Takeshita A, Nose Y. Clinical characteristics
associated with myocardial infarction, arrhythmias, and sud-
den death in patients with vasospastic angina. Circulation
1987;75:1110—6.
[3] Myerburg RJ, Kessler KM, Mallon SM, Cox MM, DeMarchena
E, Interian Jr A, Castellanos A. Life-threatening ventricular
arrhythmias in patients with silent myocardial ischemia due
to coronay artery spasm. N Engl J Med 1992;326:1451—5.
[4] Kim MH, Park EH, Yang DK, Park TH, Kim SG, Yoon JH, Cha KS,
Kum DS, Kim HJ, Kim JS. Role of vasospasm in acute coronary
syndrome: insights from ergonovine stress echocardiography.
Circ J 2005;69:39—43.
[5] Beltrame JF, Sasayama S, Maseri A. Racial heterogene-
ity in coronary artery vasomotor reactivity: differences
between Japanese and Caucasian patients. J Am Coll Cardiol
1999;33:1442—52.
[6] Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M,
Mongiardo R, Cianﬂone D, Sanna T, Sasayama S, Maseri A. Major
racial differences in coronary constrictor response between
Japanese and Caucasians with recent myocardial infarction.
Circulation 2000;101:1102—8.
[7] Kugiyama K, Motoyama T, Hirashima O, Ohgushi M, Soejima H,
Misumi K, Kawano H, Miyao Y, Yoshimura M, Ogawa H, Mat-
sumura T, Sugiyama S, Yasue H. Vitamin C attenuates abnormal
vasomotor reactivity in spasm coronary arteries in patients
with coronary spastic angina. J Am Coll Cardiol 1998;32:103—9.
[8] Hirashima O, Kawano H, Motoyama T, Hirai N, Ohgushi M,
Kugiyama K, Ogawa H, Yasue H. Improvement of endothe-
lial function and insulin sensitivity with vitamin C in patients
with coronary spastic angina: possible role of reactive oxygen
species. J Am Coll Cardiol 2000;35:1860—6.
[9] Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi
M, Tsunoda R, Moriyama Y, Miyao Y, Yoshimura M, Ogawa H,
Yasue H. Vitamin E administration improves impairment of
endothelium-dependent vasodilation in patients with coronary
spastic angina. J Am Coll Cardiol 1998;32:1672—9.
10] Wispe JR, Clark JC, Burhans MS, Kropp KE, Korfhagen TR,
Whitsett JA. Synthesis and processing of the precursor for
human mangano-superoxide dismutase. Biochim Biophys Acta
1989;994:30—6.
11] Shimoda-Matsubayashi S, Matsumine H, Kobayashi T,
Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural dimor-
phism in the mitochondrial targeting sequence in the human
manganese superoxide dismutase gene. A predictive evidence
for conformational change to inﬂuence mitochondrial trans-
port and a study of allelic association in Parkinson’s disease.
Biochem Biophys Res Commun 1996;226:561—5.
2[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[10
12] Ohashi M, Runge MS, Faraci FM, Heistad DD. MnSOD deﬁciency
increases endothelial dysfunction in ApoE-deﬁcient mice. Arte-
rioscler Thromb Vasc Biol 2006;26:2331—6.
13] Fang X, Weintraub NL, Rios CD, Chappell DA, Zwacka RM,
Engelhardt JF, Oberley LW, Yan T, Heistad DD, Spector AA.
Overexpression of human superoxide dismutase inhibits oxida-
tion of low-density lipoprotein by endothelial cells. Circ Res
1998;82:1289—97.
14] Kinscherf R, Claus R, Wagner M, Gehrke C, Kamencic H, Hou
D, Nauen O, Schmiedt W, Kovacs G, Pill J, Metz J, Deigner
HP. Apoptosis caused by oxidized LDL is manganese superoxide
dismutase and p53 dependent. FASEB J 1998;6:461—7.
15] Shatrov VA, Brune B. Induced expression of manganese
superoxide dismutase by non-toxic concentrations of oxi-
dized low-density lipoprotein (oxLDL) protects against
oxLDL-mediated cytotoxicity. Biochem J 2003;374:
505—11.
16] Fujimoto H, Taguchi J, Imai Y, Ayabe S, Hashimoto H,
Kobayashi H, Ogasawara K, Aizawa T, Yamakado M, Nagai
R, Ohno M. Manganese superoxide dismutase polymorphism
affects the oxidized low-density lipoprotein-induced apopto-
sis of macrophages and coronary artery disease. Eur Heart J
2008;29:1267—74.
17] Rosenblum JS, Gilula NB, Lerner RA. On signal sequence poly-
morphisms and diseases of distribution. Proc Natl Acad Sci USA
1996;93:4471—3.
18] Hiroi S, Harada H, Nishi H, Satoh M, Nagai R, Kimura A. Polymor-
phisms in the SOD2 and HLA-DRB1 genes are associated with
nonfamilial idiopathic dilated cardiomyopathy in Japanese.
Biochem Biophys Res Commun 1999;261:332—9.
19] Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H,
Sugiyama S, Kugiyama K, Ogawa H, Ogawa Y, Saito Y, Miyamoto
Y, Nakao K. A missense Glu298Asp variant in the endothelial
nitric oxide synthase gene is associated with coronary spasm in
the Japanese. Hum Genet 1998;103:65—9.
20] Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K,
Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y, Nakao K.
T-786→C mutation in the 5′-ﬂanking region of the endothelial
nitric oxide synthase gene is associated with coronary spasm.
Circulation 1999;99:2864—70.
21] Ito T, Yasue H, Yoshimura M, Nakamura S, Nakayama M, Shi-
masaki Y, Harada E, Mizuno Y, Kawano H, Ogawa H. Paraoxonase
gene Gln192Arg (Q192R) polymorphism is associated with coro-
nary artery spasm. Hum Genet 2002;110:89—94.
[H. Fujimoto et al.
22] Mashiba J, Koike G, Kamiunten H, Ikeda M, Sunagawa K.
Vasospastic angina and microvascular angina are differentially
inﬂuenced by PON1 A632G polymorphism in the Japanese. Circ
J 2005;69:1466—71.
23] Kaneda H, Taguchi J, Kuwada Y, Hangaishi M, Aizawa T,
Yamakado M, Ogasawara K, Aizawa T, Ohno M. Coronary artery
spasm and the polymorphisms of the endothelial nitric oxide
synthase gene. Circ J 2006;70:409—13.
24] Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor
for coronary spasm. Circulation 1993;87:76—9.
25] Yasue H, Nakagawa H, Itoh T, Harada E, Mizuno Y. Coronary
artery spasm—–clinical features, diagnosis, pathogenesis, and
treatment. J Cardiol 2008;51:2—17.
26] Rubanyi GM. The role of endothelium in cardiovascular home-
ostasis and diseases. J Cardiovasc Pharmacol 1993;22:S1—14.
27] Egashira K, Inou T, Yamada A, Hirooka Y, Takeshita A. Preserved
endothelium-dependent vasodilation at the vasospastic site in
patients with variant angina. J Clin Invest 1992;89:1047—52.
28] Bräsen JH, Leppänen O, Inkala M, Heikura T, Levin M, Ahrens
F, Rutanen J, Rutanen J, Pietsch H, Bergqvist D, Levonen AL,
Basu S, Zeller T, Klöppel G, Laukkanen MO, et al. Extracellu-
lar superoxide dismutase accelerates endothelial recovery and
inhibits in-stent restenosis in stented atherosclerotic Watan-
abe heritable hyperlipidemic rabbit aorta. J Am Coll Cardiol
2007;50:2249—53.
29] Lund DD, Chu Y, Brooks RM, Faraci FM, Heistad DD. Effects
of a common human gene variant of extracellular superoxide
dismutase on endothelial function after endotoxin in mice. J
Physiol 2007;584:583—90.
30] Shuvaev VV, Tliba S, Nakada M, Albelda SM, Muzykantov
VR. Platelet-endothelial cell adhesion molecule-1-directed
endothelial targeting of superoxide dismutase alleviates oxida-
tive stress caused by either extracellular or intracellular
superoxide. J Pharmacol Exp Ther 2007;323:450—7.
31] Giardina JB, Tanner DJ, Khalil RA, Oxidized-LDL. enhances
coronary vasoconstriction by increasing the activity of pro-
tein kinase C isoforms alpha and epsilon. Hypertension
2001;37:561—8.
32] Miwa K, Fujita M, Sasayama S. Recent insights into the mecha-
nisms, predisposing factors, and racial differences of coronary
vasospasm. Heart Vessels 2005;20:1—7.
33] Shimokawa H, Takeshita A. Rho-kinase is an important thera-
peutic target in cardiovascular medicine. Arterioscler Thromb
Vasc Biol 2005;25:1767—75.
